Related Experiment Video

Updated: Dec 14, 2025

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

12.4K

[Optimization of lipid-lowering therapy in patients after ischemic stroke. Resolution of the Council of Experts]

I A Vozniuk1, N A Shamalov2, M V Ezhov3

  • 1Dzhanelidze Saint-Petersburg Research Institute of Emergency Medicine, Petersburg (ex Leningrad), Russia.

Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova
|July 18, 2020
PubMed

Insights

This study offers a practical guide for managing high cholesterol in patients who have had an ischemic stroke. It details a treatment algorithm using statins, ezetimibe, and PCSK9 inhibitors to lower LDL cholesterol effectively.

Area of Science:

  • Cardiovascular Medicine
  • Neurology
  • Pharmacology

Background:

  • Hyperlipidemia is a primary risk factor for atherosclerotic diseases, notably ischemic stroke.
  • Effective lipid management is crucial for secondary prevention in post-stroke patients.

Purpose of the Study:

  • To provide practical recommendations for lipid-lowering therapy in patients following an ischemic stroke.
  • To present a sequential treatment algorithm to achieve target low-density lipoprotein cholesterol levels.

Main Methods:

  • Development of a treatment algorithm for lipid management.
  • Sequential administration of lipid-lowering agents including statins, ezetimibe, and PCSK9 inhibitors.
  • Focus on achieving target low-density lipoprotein cholesterol levels.

Main Results:

  • The proposed algorithm guides the stepwise use of lipid-lowering therapies.
  • Achieving target low-density lipoprotein cholesterol levels is facilitated by the sequential approach.
  • The recommendations aim to optimize secondary prevention strategies.

Conclusions:

  • The developed algorithm offers a structured approach to prescribing lipid-lowering therapy for post-ischemic stroke patients.
  • This strategy aids clinicians in managing hyperlipidemia and reducing atherosclerotic disease risk.
  • Optimized lipid management is essential for improving outcomes in patients with a history of ischemic stroke.

Keywords:
strokestatinsPCSK9 inhibitorscardiovascular death

More Related Videos

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

15.0K
A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia06:01

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia

Published on: August 18, 2015

15.3K

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
255
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.2K
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
166
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
161
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
244
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
515